What is Heron Therapeutics, Inc. (HRTX)?
Heron Therapeutics, Inc. is a biopharmaceutical company engaged in the development and commercialization of innovative therapies primarily in the oncology and supportive care fields. The company focuses on addressing unmet medical needs through novel drug formulations and delivery methods. Its product portfolio includes treatments designed to improve patient quality of life during cancer therapy, such as antiemetics and pain management solutions. Heron Therapeutics invests in research and development to advance its pipeline of therapeutic candidates. The company collaborates with healthcare providers and regulatory agencies to bring its products to market. It operates within the pharmaceutical industry, emphasizing scientific innovation and clinical efficacy. Heron Therapeutics aims to contribute to advancements in cancer care and supportive treatments through its specialized pharmaceutical offerings.
Heron Therapeutics, Inc. Stock Price Today: Live Overview
The price today is shaped by current market motions, as Heron Therapeutics, Inc. trades at $0.91. The price has moved within the bounds of $0.86 and $0.93, showing a daily percentage shift of 0%.
FAQ: Heron Therapeutics, Inc. (HRTX)
What is the current price of HRTX stock?
Heron Therapeutics, Inc. is priced at $0.91 currently.
Does HRTX pay dividends?
Heron Therapeutics, Inc. does not pay dividends.
Does HRTX have a formal corporate presence or regional headquarters in the UAE?
Heron Therapeutics, Inc. has no official regional office or subsidiary in the UAE and operates via partners only.
What is HRTX best known for?
The company is most famous for developing innovative pharmaceutical products.
What assets are typically shown together with HRTX?
Commonly shown alongside HRTX: Loar Holdings Inc, Monte Rosa Therapeutics Inc, Bio-Techne Corp
Latest shares articles



